Aquestive Therapeutics, Inc. (AQST) short interest & options flow
NASDAQAQST utilization hits 91%, down from 100% yesterday but near its 52-week peak, as short interest sits elevated at 23.5% of free float with borrow availability critically tight at 1.7%.
- Market cap
- $491M
- Next earnings
- 5 Mar 2027
Key data as of 14 Nov 2026

Latest signals on AQST
- Utilization
AQST utilization hits 91%, down from 100% yesterday but near its 52-week peak, as short interest sits elevated at 23.5% of free float with borrow availability critically tight at 1.7%.
AQST news and analysis
RSSNo long-form analysis yet for AQST. Pulse alerts and the live data picture are available on ORTEX.
Open AQST on ORTEX →Want the live picture for AQST?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AQST — free to start on ORTEX.
Sign up for free →Open AQST on ORTEX